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Abstract
Imaging of cancer with 18F-fluorodeoxyglucose positron emission tomography (18F-FDG
PET) has become a standard component of diagnosis and staging in oncology, and is
becoming more important as a quantitative monitor of individual response to therapy. In this
article we investigate the challenging problem of predicting a patient’s response to neoadju-
vant chemotherapy from a single 18F-FDG PET scan taken prior to treatment. We take a
“radiomics” approach whereby a large amount of quantitative features is automatically
extracted from pretherapy PET images in order to build a comprehensive quantification of
the tumor phenotype. While the dominant methodology relies on hand-crafted texture fea-
tures, we explore the potential of automatically learning low- to high-level features directly
from PET scans. We report on a study that compares the performance of two competing
radiomics strategies: an approach based on state-of-the-art statistical classifiers using over
100 quantitative imaging descriptors, including texture features as well as standardized
uptake values, and a convolutional neural network, 3S-CNN, trained directly from PET
scans by taking sets of adjacent intra-tumor slices. Our experimental results, based on a
sample of 107 patients with esophageal cancer, provide initial evidence that convolutional
neural networks have the potential to extract PET imaging representations that are highly
predictive of response to therapy. On this dataset, 3S-CNN achieves an average 80.7%
sensitivity and 81.6% specificity in predicting non-responders, and outperforms other com-
peting predictive models.
Introduction
Neoadjuvant chemotherapy (NC) for cancer treatment is often given as a first step before the
definitive surgery of a tumor, in order to facilitate surgical resection and improve the likelihood
of a R0 resection [1], i.e. where there is a clear surgical margin on the pathological specimen.
NC has been associated with improved survival after surgery for patients who respond to the
therapy, and is considered the standard of care in some cancers [2, 3]. On the other hand, for
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patients who do not respond to NC, the prognosis after therapy is generally worse compared to
primarily surgical approach alone [4]. When NC is not effective, it has also the disadvantage of
exposing patients to unnecessary toxicity and may lead to adverse events while substantially
increasing the associated health care costs and delaying definitive treatment. Identifying novel,
non-invasive approaches for pretherapy prediction of NC response therefore holds the promise
to stratify patients for preoperative therapy and has the potential to substantially improve the
clinical outcome for certain patient populations or at least individualize treatment regimes.
Positron emission tomography (PET) is a nuclear medicine imaging technique based on the
measurement of gamma rays resulting from positron emission using radiolabelled tracer mole-
cules. These radiotracers allow biological processes to be measured and whole body images to
be obtained which demonstrate sites of radiotracer accumulation. One of the most common
radiotracers in use today is 18F-fluorodeoxyglucose (18F-FDG), a radiolabelled sugar (glucose
analog) molecule. Imaging with 18F-FDG PET is used to determine sites of abnormal glucose
metabolism and can be used to localize and characterise many types of tumor non-invasively.
There is extensive evidence in the literature indicating the importance of 18F-FDG PET imag-
ing in accurately characterizing disease, as well as determining stage and sites of recurrent dis-
ease in many cancer types [5]. For these indications, functional imaging with PET provides
unique information which is not generally available from other standard medical imaging
modalities such as CT and MRI.
Despite early indications that 18F-FDG PET imaging may also be a viable approach for pre-
dicting NC response using pre-treatment imaging [6], only a handful of quantitative measure-
ments or biomarkers carrying predictive power have been found to be clinically useful. Some
evidence has been reported that the amount of FDG uptake on pretreatment scans, as mea-
sured by tumor metabolic concentrations known as Standardized Uptake Values (SUVs) may
carry predictive power [7–9]. The rationale for this approach is that the elevated FDG uptake
in malignant cells is hypothesized to be associated with biologically relevant features, such as
perfusion, cell proliferation, tumor viability, aggressiveness, and hypoxia [10–12], which are
predictive of resistance to chemotherapy. However, SUV measurements are significantly
affected by the initial 18F-FDG uptake kinetics and radiotracer distribution, which depend on
the initial radiotracer injected activity as well as on the time elapsed between the tracer injec-
tion and the image acquisition. These factors can complicate the interpretation of SUV mea-
surements due to their significant intra- and inter-observer variability [13]. For these reasons,
and the fact that response prediction is not sufficiently accurate to use in the clinic, SUV mea-
surements so far have been proved to be most useful in studies investigating the role of PET
imaging to track 18F-FDG uptake changes over the course of an existing treatment [14, 15]
rather than in predicting response from a single PET scan prior to therapy.
A particularly promising research direction that could potentially overcome the above limi-
tations consists of the high-throughput extraction of large amounts of imaging features that
can be made in direct relationship with clinical endpoints of interest. Radiomics [16, 17], an
emerging field of research concerned with this objective, can potentially have a large clinical
impact, since imaging is routinely used in clinical practice world-wide. In PET imaging, there
has been increasing interest in identifying imaging features that characterize the spatial distri-
bution and heterogeneity of 18F-FDG uptake patterns within a tumour by image analysis [18,
19]. This heterogeneity is hypothesized to originate in a number of physiological factors such
as tumor metabolism, necrosis, cellularity, and angiogenesis, amongst others, and variability in
these factors has been associated with more aggressive cancer behaviour, poorer response to
treatment and worse prognosis [10–12]. The dominant methodologies for obtaining quantita-
tive descriptors of spatial heterogeneity rely on texture analysis [20]. Such techniques encom-
pass a broad range of mathematical descriptors that can be used to evaluate the spatial
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variation of voxel intensities both within a single PET slice as well as between adjacent slices,
thus providing measures of intra-lesional heterogeneity. In contrast to SUVs, these descriptors
provide a more accurate spatial characterization of FDG uptake patterns, and can potentially
capture more signal. Whilst recent studies have started to explore the benefits of texture analy-
sis for predicting response to NC therapy [21–25], drawing definite conclusions is difficult as
each study relies upon different definitions of texture and deploys different predictive models.
Another limiting factor characterising existing studies has been the small sample sizes, typically
ranging from 10 to 50 patients.
The objective of this work is two-fold. First, we set out to explore whether a machine learn-
ing algorithm would be able to infer a predictive representation of a cancer’s metabolic profile,
as captured by 18F-FDG PET imaging, in a larger patient population. In very recent years, bio-
logically-inspired convolutional neural networks (CNN) have shown the ability to learn hierar-
chically-organised, low- to high-level features from raw images [26, 27], and yield state-of-the-
art performance in the classification of both natural and medical images [28–31]. To investi-
gate this question, we propose a neural network to harness the predictive power of spatially-
varying 18F-FDG PET uptake patterns. The proposed architecture, 3S-CNN (three-slices con-
volutional neural network), produces features that are representative of metabolic activity in
cancer, before therapy, and we expect that this method would ultimately distinguish responders
to non-responders. Our second objective is to compare the performance of 3S-CNN with com-
peting predictive algorithms where the quantitative tumour phenotypes are represented by
over 100 “hand designed” texture features, capturing patterns in both two- and three-dimen-
sions, as well as SUV summaries. Whereas previous studies have each reported on the perfor-
mance of a very specific approach, generally combining a handful of selected texture features
with a single statistical classifier, here we aim at a more comprehensive empirical characteriza-
tion of a large battery of quantitative descriptors and predictive models. In this respect, our
results set a comparative benchmark for future radiomics developments in this area.
Material and methods
Oesophageal cancer data
For this study we obtained a dataset consisting of n = 107 patients (83 males, 24 females) with
newly diagnosed esophageal cancer at a tertiary referral centre, Guys and St Thomas NHS
Trust (GSTT). The study was approved by the Westminster ethics committee, and all patient
information was anonymized prior to analysis. The age at time of diagnosis ranged from 32 to
80 with an average of 62±25 years. All patients underwent pre-treatment whole-body 18F-FDG
PET/CT for staging. For each patient, the primary tumor was positively identified on axial
18F-FDG PET images by an experienced nuclear medicine physician.
Bespoke software was developed for the automatic delineation of the tumor ROIs. This was
achieved by applying a 40% slice-wise maximum intensity threshold to exclude voxels with less
than 40% of the activity in the voxel of maximum intensity within the same axial slice. Using
this approach we were able to accurately delineate the regions of high 18F-FDG uptake across
all tumors in the study. Each pixel corresponded to a voxel size of 4.7 × 4.7mm with 3.27mm
slice thickness, and the size of the slices in the dataset varies from 13 × 16 to 93 × 79 pixels.
Also, as can be observed in Fig 1, there is a wide inter individual variability in the number of
axial slices which were extracted from the 3D tumor volumes. The number of axial slices per
tumor varied from 4 to 32. 86 tumors were adenocarcinoma, 20 were squamous cell carcinoma,
and one was undefined. Nearly half of the patients had a moderately differentiated tumour
(58). 70 patients had a T3 primary lesion, 80 had N1 lymph node metastasis, and 1 patient had
distant metastasis. All patients were treated with neoadjuvant chemotherapy, and 38 responded
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to treatment. The response was assessed using a pathological Mandard tumor regression grade
[32]. For the purpose of this study, we grouped the patients into two distinct pathologic groups:
the non-responders group, which includes subjects whose tumor showed no regressive changes
(Grades 4 and 5), and the responders group, which includes all those cases in which regressive
changes were noted (Grades 1, 2 and 3) as originally proposed in [32]. Among the responders,
26 (68.4%) had TNM clinical stage III; among the non-responders, 20 (29.0%) had clinical
TNM stage II. The overall survival (OS) period was defined as the time in days between the
PET scan and the date of death. Responders to therapy had a median OS of 972.5 days com-
pared with 714 days for non-responders. Fig 2 illustrates the overall survival rates, which were
found to be significantly different by a Kaplan-Meier analysis (p-value = 0.00045).
Texture analysis
Texture analysis refers to a variety of mathematical methods used to provide information
about the spatial arrangement of voxel intensities within a volume neighborhood containing
the tumor [21, 25]. In our study, we used texture analysis to characterize the 3D uptake hetero-
geneity in a tumor that is captured by the PET scans. We employed two broad classes of texture
feature extraction techniques, statistical- and model-based. The statistical approach consisted
of quantifying some aspects of the spatial distribution of voxel values by taking into account
local features at each point in the image, and extracting a set of statistics from the distributions
of these features.
The statistics-based approach relies on first-, second- and higher-order statistics. First-order
statistics were calculated from the original voxel intensity values without taking into consider-
ation the relationship of each voxel with its neighbors. This class encompassed measures of
central tendency (including mean, median, mode, percentiles, quartiles), variability (including
range, interquartile range, variance, standard deviation, coefficient of variation, skewness, and
kurtosis), first order energy, and entropy. Second order statistics consist of co-occurence mea-
surements between two pixels calculated using both Gray-Level Co-occurrence Matrices
Fig 1. Distributions of axial 18F-FDG PET intra slices extracted from the 3D tumor volume of non-responders and responders.
doi:10.1371/journal.pone.0137036.g001
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(GLCMs) [33] and Gray-Level Difference Matrices (GLDMs) [34]. GLCMs determine how
many times a voxel with a given intensity occurs jointly with another voxel having a different
intensity, whereas GLDMs are based on absolute differences between pairs of voxel intensities.
Higher order statistics capture properties of three or more voxel values occurring at specific
locations relative to each other, and are extracted from Gray-Level Run Length Matrices
(GLRLMs) [35], Gray-Level Size Zone matrices (GLSZMs) [36] and Neighborhood Gray-Tone
Difference Matrices (NGTDMs) [37]. Both GLRLMs and GLSZMs analyze texture in a specific
gray-level run and zone, respectively. Gray-level run is the length of consecutive voxels having
the same intensity in a preset direction in the image, whereas the zone is a cluster of consecu-
tive voxels having the same intensity. A GLRL matrix is a two-dimensional matrix in which
each element p(i, jjα) gives the total number of occurrences of runs of length j at gray level i in
a specific direction α. Following the same principle, the entries of a GLSZ matrix are the num-
ber of clusters of size s of gray-level i, where the size of a cluster is defined as the number of
consecutive pixels with gray-level i. Finally, NGTDM are column matrices that describe the dif-
ferences between each voxel and its neighboring voxels in adjacent image planes, and are
thought to closely resemble the human experience of the image [37]. In NGTDM, the ith entry
is a summation of the differences between all pixels with gray-tone i and the average value of
their surrounding neighbors.
Model-based approaches used mathematical models such as fractal analysis to represent
texture information. Fractal analysis is a form of geometric pattern recognition that evaluates
the self-similarity and roughness of a surface at different levels [38, 39]. Such evaluation in the
context of PET imaging can quantify the 18F-FDG uptake heterogeneity of a tumor volume
[40, 41]. A fractal is defined as a set for which Hausdorff-Besicovich dimension is strictly
greater than the topological dimension [42]. The fractal dimension (FD) is the defining prop-
erty in the study of texture analysis. The fractal dimension of each voxel of the 18F-FDG uptake
is calculated inside a moving window centred on the voxels by using a differential box-counting
method [43]. A summary of the texture matrices and the extracted texture features we have cal-
culated is provided in Table 1. In total we considered 85 texture features, on top of which we
then added 18 statistical summaries of SUV measurements (including minimum, maximum,
Fig 2. Kaplan-Meier plot showing the survival rates of responders and non-responders.
doi:10.1371/journal.pone.0137036.g002
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mean). By including all the above features, for each tumor volume i, we end up extracting a
quantitative descriptor of the ROI consisting of a 103-dimensonal vector denoted
ti ¼ ðti;1;    ; ti;103Þ, for i = 1, 2, . . ., n.
The individual feature vectors ti obtained for the pretherapy PET scans were used as predic-
tors to train and test state-of-the art machine learning techniques for the prediction of NC
therapy response. The objective was to minimize the classification error on unseen test data.
We considered four different statistical classifiers: logistic regression (LR) [44], gradient boost-
ing (GB) [45], random forests (RF) [46], and support vector machines (SVM) [47]. Logistic
regression is a common linear method for multi-variable modeling of binary outcomes. Both
GB and RF embrace the notion of ensemble learning, whereby an entire collection of learning
algorithms is deployed in order to obtain superior predictive performance. More explicitly, GB
algorithm builds an ensemble of regression trees in a stage-wise fashion, where each one is
trained with respect to the error of the whole ensemble learnt so far. On the other hand, the RF
algorithm builds an ensemble of de-correlated classification trees, where each one is trained on
a random subsample of the training dataset and then combines the trained classification trees
by averaging their probabilistic prediction. Finally, the kernel-based SVM algorithm
Table 1. Summary of second and high order texture features extracted from texture analysis.
Texture Matrices Texture Features
Gray Level Co-occurence Energy, Autocorrelation,
Cluster Prominence, Cluster shade,
Contrast, Correlation, Difference Entropy,
Difference Variance, Dissimilarity,
Entropy, Homogeneity, Difference Moment
Information Measure Cor.1/Cor.2,
Sum Average, Sum Entropy, Sum Variance
Inverse Difference Moment Normalized,
Inv. Difference. Normalized, Max. Probability,
Gray Level Run Length Short Run Emphasis, Long Run Emphasis,
Short Run Low/High Gray Level Intensity,
Long Run High/Low Gray Level Intensity,
Run Length Non-uniformity,Run Percentage,
Intensity Variability, Run Length Variability
High/Low Gray Level Run Emphasis,
Gray Level Size Zone Short/Long Zone Emphasis, Zone Percentage,
Short Zone Low/High Emphasis,
Long Zone High/Low Emphasis,
Intensity Non-uniformity,
Zone Length Non-uniformity,
Low/High Intensity Zone Emphasis,
Intensity Variability, Size zone Variability
Gray Level Difference Mean, Entropy, Variance, Contrast
Fractal Based Features Mean, Standard Deviation,
Hurst Exponent, Lacunarity
Neigh. Gray Tone Difference Coarseness, Contrast, Busyness,
Texture Strength, Complexity
doi:10.1371/journal.pone.0137036.t001
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discriminates between responders and non-responders using hyperplanes that maximize the
margin between the two classes in a non-lineal feature space. The key idea of kernels is to proj-
ect the input explanatory variables of our dataset into high dimension hyperplanes where the
discrimination between responders and non responders is improved.
Convolutional neural networks
A Convolutional Neural Network (CNN) is a special feed-forward neural network for learning
a hierarchical representation of imaging data [26, 27] and then using these representations for
imaging recognition tasks. In traditional classifiers like LR, SVM, GB and RF, there is a need
for preprocessing the images and to extract texture features relevant to a specific task. The limi-
tation of these classifiers originates from the fact that the performance is highly dependent on
the design of the texture features, thus requiring prior knowledge for a specific task and exper-
tise in hand-engineering the necessary features. By contrast, CNN operates directly on raw
images and attempts to automatically extracts highly expressive imaging features relevant to a
specific task at hand.
Compared to standard neural networks, the individual neurons in a CNN are tiled in such a
way that they respond to overlapping portions of the input image. The main architectural com-
ponents of CNN are the convolutional and subsampling layers. The neurons of the convolu-
tional layer receive information from only a subset of the inputs, called receptive field. As a
result, each neuron learns to detect features from a local region of the input image. This allows
us to capture the local substructure and preserve the topology of the input image. In addition
to local connectivity, a convolutional layer also imposes groups of neurons, whose receptive
fields are located in different places of the input image, to share exactly the same weight values.
The outputs of these groups of neurons are called feature maps. The technique of the weight
sharing reduces the number of free parameters, thus increasing the generalization ability of the
network [48]. A convolutional layer is composed of several feature maps, so that a rich variety
of imaging features can be extracted. The convolutional layers are then followed by subsam-
pling layers whose purpose is to reduce the dimensionality of the convolutional responses by
selecting superior invariant imaging features. In an attempt to achieve a distributed and more
abstract representation of the input image, multiple convolutional-subsampling layers are
stacked on top of one another, thus delivering a deep architecture of multiple non-linear trans-
formations. Each layer generates a representation of the image based on the feature-detecting
role of the neurons. By stacking layers of feature-detecting neurons, a CNN is able to infer
highly expressive representations carrying predictive power for imaging recognition tasks [28].
In our application the object to be classified is a ROI representing the tumor, which has a
three-dimensional shape. Using ROIs as direct input of the CNN is infeasible due to the fact
that every tumor has a different shape and size. To address this issue, we initially embedded all
individual ROIs into 3D cuboids of standard width and length, and height varying according to
the number of slices of each ROI. Specifically, each 2D intra-tumor slice was embedded into a
larger and squared background of standard size 100 × 100 pixels, which was sufficiently large
to include all the observed tumors (see Fig 3). For a given tumor i havingmi slices, we denote
each enlarged slice as xi,j where i = 1, 2, . . ., n and j = 1, 2, . . .,mi. We denote the entire stan-
dardized volume containing the tumor for patient i as xi. Our assumption is that a neural net-
work architecture able to capture patterns of FDG uptake that occur within each 2D slice as
well as across multiple adjacent slices may detect salient imaging features that are important
for predicting chemotherapy response. Under this assumption, we propose an architecture that
initially fuses the spatial information across adjacent intra slices. For a given standardized vol-
ume xi containingmi slices, we build all possible sets of three adjacent slices, which we denote
Predicting Response to Neoadjuvant Chemotherapy with PET Imaging
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as zi;k ¼ fxi;k;xi;kþ1;xi;kþ2g where k = 1, . . .,mi − 2. This process is illustrated in Fig 3. Each
triplet zi,k was then treated as a three-channel input for the CNN. Associated with each triplet
zi,k there is a corresponding binary label, yi, k, indicating whether the patient has responded (yi,
k = 1) or not responded (yi, k = 0) to therapy.
The first convolutional layer of the CNN, denoted U(1), consists of R(1) feature maps. Each
feature map is obtained by convolving all slices within a triplet zi,k with a weight matrix k
ð1Þ
p;j , to
which we then add a bias term bð1Þj . The output is then passed through an hyperbolic tangent
function f (), i.e.
u
ð1Þ
j ¼ f
X2
p¼0
kð1Þp;j xi;kþp þ bð1Þj
 !
j ¼ 1; . . . ;Rð1Þ:
Each element of a feature map uð1Þj in the first convolutional layer enclose information from
a local 3D tumor uptake region. The R(1) weight matrices, one for each feature map, are learned
in order to build a library of low-level features which are extracted by inspecting various loca-
tions of the input triplet. Within each PET slice, the same weight matrix is convolved with the
entire slice. This results in the weight being shared by many overlapping squared sub-windows
of the slice, and also in sparse connections between the input units and the hidden units in the
first layer.
Once each feature has been learned, its exact location within the triplet becomes less impor-
tant, as long as its approximate position relative to other features is preserved. The convolu-
tional layer is then followed by a subsampling layer which reduces the dimensionality of each
feature map. This is achieved by retaining only the maximum value within each non-overlap-
ping sub-region of size (2 × 2) for each feature map. This max-pooling operation is carried out
in order to down-sample each feature map by a factor of 2 along each direction and improve
generalization performance by selecting invariant features [49]. The max-pooling layer has the
same number of output and input feature maps and does not require any additional
parameters.
In order to extract higher-level features from the low-level features obtained in the initial
layers, additional convolutional layers are added, which are always followed by a pooling layer.
Fig 3. 18F-FDG PET ROIs of a specific tumor i after segmentation embedded into larger square background of standard size of 100 × 100 pixels.
Each enlarged slice is denoted by xi,j and each set of three spatially adjacent enlarged slides is denoted by zi,k, where j and k represent the slices and triplets
of the specific tumor i. In this example only 3 triplets, from the 5 available slices can be formed, so k = 1,2,3.
doi:10.1371/journal.pone.0137036.g003
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Each additional convolutional layer spans all the pooled feature maps obtained at the previous
layer (see Fig 4). For instance, each feature map in the second layer is obtained as
u
ð2Þ
j ¼ f
XRð1Þ
p¼1
kð2Þp;j vð1Þp þ bð2Þj
 !
j ¼ 1; . . . ;Rð2Þ:
The complete architecture contains four convolutional/max-pooling layers (see Fig 4). The
resulting set of max-pooled feature maps vð4Þj , j = 1, 2, . . ., R
(4) enclose the entire spatial local
information as well as the rich hierarchical representation of the input triplet zi,k. Each feature
map vð4Þj is then flattened out and all the elements are collected into a single vector v of dimen-
sion R. These units provide the input for a fully connected (FC) hidden layer, h consisting ofH
units. The activation of the jth unit of the FC layer is given by
hj ¼ f
XR
k¼1
Mkjvk þ bj
 !
; j ¼ 1; . . . ;H:
All weights are collected into a matrixM. The probability that each zi,k is assigned to class 1
(responder) is given by the soft-max function
pðy^ i;k ¼ 1jh; y1; y2Þ ¼
exp fy1hgP2
j¼1 exp fyjhg
;
where the vectors y1 and y2 are the columns of the softmax matrixYH2 According to this rule,
a triplet zi,k is assigned to class 1 when pðy^ i;k ¼ 1Þ > 0:5. In case of ties, we take the prediction
as being wrong.
Fig 4. CNN architecture for fusion of 3 adjacent 18F-FDG PET intra slices into a vector v. The CNN architecture is composed from 4 convolutional and 4
max-pooling layers denoted by fUðiÞg4i¼1 and fVðiÞg4i¼1. In the first convolutional layer U(1), different coloured arrows represent the usage of different learnable
weight matrices for convolving each PET slice in the triplet. Colored dotted rectangles in the feature maps represent elements of the feature maps that
enclose local spatial information of the previous layer in the architecture. In the Max-pooling layers 2 × 2 element windows represent non-overlapped grids
from which we choose the maximum element to downsample the feature maps.
doi:10.1371/journal.pone.0137036.g004
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In order to predict whether an unseen tumor volume xi respond or not to the therapy, we
use a majority vote rule based on the estimated prediction probabilities for all triplets extracted
from the tumor. We predict that xi is a responder when
1
mi  2
Xmi2
k¼1
Iðy^ i;k ¼ 1Þ > 0:5;
where I() is an indicator function that is 1 when y^ i;k ¼ 1 and otherwise is zero.
The parameters of the CNN consists of all the convolutional weights kðlÞj;Rl , the weight matrix
M and the soft-max parameter matrixYH2. These unknown parameters, denoted byW, are
learned by minimizing the negative log-likelihood function,
‘ðWÞ ¼ 
Xn
i¼1
log ðpðy^ i;k ¼ yi;kjzi;k;WÞÞ: ð1Þ
In our experiments we used a stochastic gradient-descent algorithm with mini batches
(MSGD). MSGD is a variant of the gradient descent algorithm commonly used to train neural
networks on large datasets [50]. At each update of the weights in the SGD algorithm, instead of
considering all the training data to compute the gradient of the loss function ℓ, only one small
batch of training data at a time is used. We also take advantage from the parallelization of the
MSGD algorithm in order to accelerate the training of our CNN on GPU cards. Our code is
based on Theano, a Python library that compiles symbolical expressions into C/CUDA code
for deployment on both CPUs and GPUs [51].
Comparative analysis
We carried out a comparative analysis of different machine learning algorithms for NC therapy
response prediction. As well as the 3S-CNNmodel, which takes sets of intra-tumor triplets as
input, we also implemented a simpler 1S-CNN architecture that treats each individual slice xi,k
as an independent sample, and eventually make a decision based on a majority vote rule,
exactly as in 3S-CNN. This simpler architecture is added here to study the potential advantages
deriving from exploiting inter-slice patterns that capture 3D information as in 3S-CNN. The
performance of all comparable algorithms were obtained by averaging the outcome of three
independent experiments. Each experiment was conducted using a different combination of
training and test sets. In each case, 96 patients were assigned to the training set, and the
remaining 11 were utilized for testing.
For the 3S-CNN architecture, each training set consisted of all triplets of adjacent 18F-FDG
PET slices extracted from the tumors, and each triplet was treated as a training example. Fur-
thermore, in order to create more training examples and prevent our CNNmodel from overfit-
ting, the training set was artificially augmented by rotating each triplet by κ60°, κ = 1,2,3,4,5.
Overall, we created a balanced training dataset of 5316 FDG-PET triplets for both responders
and non-responders to therapy. Training of the 1S-CNN architecture was done in a similar
way, whereby each slice within a tumour contributed a training example. For fair comparisons
between CNNmodels, the same augmentation strategy was always used. For the purpose of
tuning and optimising all the hyperparameters, which include the number of layers, weight
matrices size, and number of feature maps in each layer and learning rate, 30% of the training
dataset was used as validation set.
The predictive models trained on texture and SUV features are denoted LR, GB, RF, and
SVM when using the original feature vectors, and LR-PCA, GB-PCA, RF-PCA and SVM-PCA
when using the ten largest principal components extracted from the feature vectors. PCA was
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used to reduce the dimensionality of the input by a factor of 10 whilst retaining as much infor-
mation as possible. For each model we deployed a grid search using 10-fold cross validation to
choose the set of hyperparameters. In 10-fold cross-validation, the original training sample is
randomly partitioned into 10 equal size subsamples. Of the 10 subsamples, a single subsample
is retained as the validation data for testing the model, and the remaining 9 subsamples are
used as training data. The cross-validation process is then repeated 10 times, with each of the
10 subsamples used exactly once as the validation data. The 10 results from the folds can then
be averaged to produce a single estimation. For the SVM classifier we tested linear, polynomial
and Gaussian kernels, and here report only on the best SVM performance, which was obtained
by the polynomial kernel.
The forward stage-wise fashion of the GB allows us to automatically assess the contribution
of each variable in the construction of a robust classification rule [52]. In the GB algorithm at
each node of each regression tree a specific variable is used to partition the sample of patients
associated with that node into subregions. The particular variable chosen is the one that gives
maximal estimated improvement in squared error risk over that for a constant fit over the
entire sample of patients. In each regression tree, the squared relative importance of this vari-
able is the sum of such squared improvements over all the internal nodes for which it was cho-
sen as the splitting variable. This importance measure can be generalized to the forward stage-
wise expansion of regression trees of the GB algorithm by simply averaged over the trees which
were induced in the ensemble.
We also examined the performance of a classifier based only on SUVmax measurements.
The SUVmax summaries were thresholded by performing a receiver operating characteristic
(ROC) analysis. The optimal threshold was identified by means of a grid search using values
within the range of the SUVmax measurements extracted from the training dataset. From the
ROC curve we chose the threshold associated to the maximum sum of true positive and true
negative rates. Then we classified each of the remaining 11 patients as responders if the corre-
sponding SUVmax measurement was below the threshold.
Finally, we explored a potential association between response to treatment and TNM stag-
ing and grading, as these two parameters are commonly adopted in clinical practice. TNM
stages were divided into two groups, stage II and stage III, and the strength of their association
was not found to be statistically significant (p-value = 0.73) using a Pearson’s χ2 test. Analo-
gously, a potential association between the grading system and response to therapy was tested
by first lumping together well and moderately differentiated tumours into one group, and
using poorly differentiated tumors as second group. Again, there was no evidence of a statisti-
cally significant association (p-value = 0.41).
Experimental results
The performance metrics relative to all the predictive models are summarized in Table 2. Speci-
ficity represents the proportion of actual respondents (positives) which are correctly identified
as such, and the sensitivity represents the proportion of non-respondents (negatives) which are
correctly identified as such. In terms of average accuracy, the 3S-CNN algorithm outperforms
all other models, and its performance is followed by a GB algorithm trained on hand-crafted
features. Excluding LR, all the classifiers trained on texture features perform better when the
feature vector is replaced by principal components. Finally, we note that apart from the
3S-CNN algorithm, all other algorithms were outperformed by the SUVmax median threshold.
Fig 5 reports the top 10 features and their corresponding score extracted from the GB algo-
rithm. In this figure the feature with largest importance has been given a score of 100%, and all
the other features have been scaled accordingly. From this feature ranking analysis it emerges
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Table 2. Classification results: each figure is the average of three independent experiments using dif-
ferent training and test datasets.
Method Sensitivity Specificity Accuracy
3S-CNN 80.7±11.5 81.6±9.2 73.4±5.3
1S-CNN 77.9±12.9 58.3±4.2 66.4±5.9
GB 70.5±6.0 63.8±6.1 66.7±5.2
GB with PCA 68.1±7.9 46.8±16.2 66.8±6.0
RF 61.0±8.6 36.4±18.4 57.3±7.8
RF with PCA 65.8±7.5 52.0±28.9 65.7±5.6
SVM 66.9±8.5 38.4±19.2 55.9±8.1
SVM with PCA 67.4±10.3 50.9±5.0 60.5±8.0
Logistic Reg. 60.4±6.2 38.3±7.3 51.4±3.0
Logistic Reg. with PCA 58.9±4.9 38.9±12.5 48.4±8.0
SUV max with threshold 33.0±33.0 35.2±10.2 41.0±4.5
SUVmax median threshold 81.5±1.5 53.0±13.0 67.7±4.2
doi:10.1371/journal.pone.0137036.t002
Fig 5. Tenmost important texture features for prediction of the chemotherapy response using the GB algorithm. Since these measures are relative,
we assign the largest importance a value of 100% and then scale the others accordingly.
doi:10.1371/journal.pone.0137036.g005
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that coarseness, which has been linked to granularity within an image, is the most important
feature for response prediction. Coarseness describes local tumor texture based on differences
between each voxel and the neighboring voxels in adjacent axial 18F-FDG PET images.
In Fig 6, we illustrate feature maps from the first and last max-pooling layers V(1), V(4) of
the CNN architecture. These feature maps demonstrate how a specific triplet is represented in
the first and last max-pooling layers. The feature maps in the first layer appear to have fused
the information from the three adjacent slices of the triplets. In the last layer, the 3S-CNN
architecture represents the triplets by remarkably clear and well-defined geometrical patterns
with the same level of metabolic activity.
Discussion
The experimental results in Table 2 provide evidence that 3S-CNN outperforms the predictive
algorithms trained on a large set of pre-determined imaging features. We believe that the fea-
tures produced by this approach encompass several of the standard texture features, with the
advantage of being completely automatic. The superior performance achieved by the CNN
algorithm is due to the exploitation of 3D 18F-FDG uptake information captured by the PET
scans and the fact that the architecture learns imaging features that are directly relevant to the
clinical endpoint. To our knowledge, the potential predictive power of deep neural networks
that only use the raw data as input, and build internal representations of the PET images, has
never been assessed for the prediction of chemotherapy response.
Fig 6. Examples of feature maps in the first and last max-pooling layers V(1) , V(4) of the CNN architecture. The feature maps illustrate how a specific
triplet is represented in the first and last max-pooling layers.
doi:10.1371/journal.pone.0137036.g006
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In the literature, the decrease in mean or maximum metabolic activity measured by SUV
parameters within the first two weeks of neoadjuvant therapy is often considered to be the best
available predictor of histopathologic tumor response, however the sensitivities and specifici-
ties are still below 67 − 70% (95% confidence intervals ranging from 62% to 76%) [53, 54].
Beyond the prognostic role of FDG uptake changes over the course of the treatment, the role of
SUV parameters from only baseline 18F-FDG PET images has been investigated in various
studies [7–9], but results conflict as to whether SUV parameters carry any predictive power to
assess response to therapy. Specifically, two studies reported that patients with high initial
SUVmax values associated with higher probability of response to chemoradiation while one
study reported that SUV measurements were not significant factors of the response.
Two studies have explored the capacity of textural features extracted from only pretherapy
PET images to differentiate patients with respect to response to therapy. Tixier et al. [21] have
analyzed the association between 38 textural features extracted from pretherapy 18F-FDG PET
images of 41 patients with esophageal cancer and response to therapy using the Kruskal-Wallis
non-parametric test. The sensitivity and specificity reported here varied from 46% to 92% and
45% to 91%, respectively. The predictive capacity of SUV parameters and textural features
extracted from GLCMs and NGTDMs has been investigated by Cheng et al. [55] in a cohort of
70 patients with esophageal cancer. This study reported AUC (area under the curve) values of
0.662 for SUV entropy and 0.663 for uniformity. Finally, several studies have investigated the
role of textural features and SUV parameters from pretherapy 18F-FDG PET images in predict-
ing response to therapy in breast, lung, cervix and head and neck cancers, reporting AUC val-
ues between 0.7 and 1.0 [22–25]. In particular, Cook et al. [25] carried out a Kaplan-Meier
analysis to analyze the association between textural features and survival outcomes such as
overall survival (OS), progression free survival (PFS) and local PFS. They reported sensitivity
and specificity to have varied between 59% to 94% and 42% to 63%, respectively. The main lim-
itation in these studies is the use of low sample sizes ranging from 9 to 53. Thus, the role of
these metrics and the clinical relevance remains to be further validated.
From the results in Table 2, it is particularly interesting to notice the difference in perfor-
mance between 1S-CNN and 3S-CNN. These results enhance the belief that local 3D informa-
tion of the 18F-FDG uptake can be beneficial for the chemotherapy response prediction.
Excluding LR, all the classifiers trained on texture features perform better when the feature vec-
tor is replaced by principal components–this is expected since several features contain redun-
dant information. Also, the threshold SUVmax median outperformed all the algorithms except
the 3S-CNN, revealing that the SUV carry predictive power. According to the rankings in Fig
5, the texture feature coarseness derived from NGTDMs is the parameter that best differenti-
ates responders and non-responders. Coarseness describes local tumor texture based on differ-
ences between each voxel and the neighboring voxels in adjacent axial 18F-FDG PET images.
This result is consistent with previously reported evidence that high coarseness values are asso-
ciated with a greater risk of local tumor progression in non-small lung cancer [25]. Moreover,
previous findings have also suggested that coarseness is a texture feature that may discriminate
well between responders to chemoradiotherapy from non-responders in oesophageal cancer
[21]. Remarkably, many texture features appearing in the top 10 ranking were extracted using
a variety of different methods, including fractal analysis, statistical based texture matrices
(including GLRLM, GLCM, GLZLSM, NGTDM) and the SUV parameter. This message
stresses again the importance of including a very large ensemble of texture features in a radio-
mics approach. Finally, from the performance of SUVmax median threshold (see Table 2) and
the importance ranking of the SUVmin (see Fig 5), our study supports the conflicting evidence
that the SUV parameters can discriminate the behavior of a tumor to treatment before therapy.
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The number of tumor volumes that is available for this study may lead to overfitting and
consequently to degradation of an algorithm’s generalization ability on unseen test examples.
The predictive algorithms we included in the comparison, such as GB, RF and SVM, encom-
pass several mechanisms to prevent overfitting [52]. For both 3S-CNN and 1S-CNN several
additional attempts were made to further reduce overfitting. For instance, we replaced the
hyperbolic tangent non-linearities with rectified linear unit (ReLu) non-linearities. Compared
to hyperbolic tangent non-linearities, ReLu accelerate the convergence of the MSGD algorithm
for the training of the CNN and it is less prone to the gradient vanishing problem [56]. Also,
we deployed the technique of Dropout in the FC layer of the CNN. Dropout prevents the neu-
rons from co-adaptation, thus reducing the overfitting of the training dataset [57]. Despite the
known advantages of these techniques, they did not significantly improve the generalization
performance in our case.
Substantial improvements would be expected by increasing the number of training PET
images for which we have clinical information. In future work will also aim at developing a
multi-modality algorithm in order to take advantage from both PET and CT images, since PET
images ignore the anatomical information and do not present well-defined tumor boundaries
because of their relatively poor spatial resolution. We believe that a combination of anatomical
and corresponding FDG uptake information will further improve the quality of extracted imag-
ing features and lead to significant improvement in the neoadjuvant chemotherapy response
prediction [58]. These model predictions could offer the potential to stratify patients for preop-
erative therapy before surgery in clinical trials.
Conclusions
Esophageal cancer is associated with high mortality and it is of vital importance to be detected
and treated in early stage. In advanced stages, preoperative chemotherapy or radiotherapy can
play an essential role in the improvement of survival for patients who respond to the treatment.
By contrast, for patients who do not respond to preoperative treatment there is a need for dif-
ferent treatment tactics in order to increase the probability of tumor control. Therefore, the
ability to noninvasively predict treatment response before therapy is of great interest and could
allow oncologists to personalize future cancer treatments in the clinic.
In the present study we have proposed two different methodologies to predict neoadjuvant
chemotherapy response based on pretherapy 18F-FDG PET images. In the first methodology,
3S-CNN were employed to hierarchically learn FDG uptake patterns that are associated with
response to neoadjuvant chemotherapy by Mandard. In the second methodology, a wide variety
of “hand-engineered” features were derived from the same images and then used as predictor
variables in machine learning algorithms. 3S-CNN algorithm outperformed all machine learning
algorithms trained on “hand-engineered” 18F-FDG PET imaging features. In conjuction with the
variety of the textural features ranked by GB algorithm, our preliminary results indicates that
synthesizing features that extensively exploit the heterogeneity of the FDG uptake information
with respect to chemotherapy response prediction might offer the potential to capture all the rele-
vant information in the 18F-FDG PET images. However, further testing using larger datasets is
required to validate the predictive power of 3S-CNN for clinical decision-making.
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